Janux Therapeutics, Inc..
JANX.US | Research and experimental development on natural sciences and engineering
Janux Therapeutics, Inc. is a biopharmaceutical company focused on developing novel immunotherapies. Their primary focus is on developing T cell engagers that are designed to selectively activate the immune system to fight cancer. They are involved in the research, development, and potential commerc...Show More
Better Health for All
0
No evidence available to assess Janux Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Janux Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess Janux Therapeutics, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
Janux Therapeutics, Inc. is a biopharmaceutical company focused on research and development. The company does not currently manufacture or distribute products, meaning it does not procure or trade physical commodities that would typically require fair-trade certifications, supplier audits for welfare, traceability of goods, or ethical sourcing clauses related to physical inputs. Consequently, the company has no exposure to upstream labor practices or high-risk materials in the context of this value.
Honest & Fair Business
-20
Janux Therapeutics has a formal whistleblower protection policy, which includes an independent third-party compliance hotline, a secure web form, and a secure hotline for reporting financial concerns.
1
This policy ensures confidentiality of reports and prohibits retaliation, with the Audit Committee responsible for receiving and addressing complaints.
2
The company also has an anti-corruption policy that specifically prohibits bribery, including compliance with the Foreign Corrupt Practices Act (FCPA).
3
Kind to Animals
-40
Janux Therapeutics conducts *in vivo* studies in HLA-A2 transgenic mice and uses *in vitro* assessments with human PBMCs, indicating that while alternative assays are employed, animal tests are still a significant part of their research.
1
The company's animal studies are conducted in accordance with guidelines established by the Smart Labs Institutional Animal Care and Use Committee under protocol 21SL09-0007, demonstrating a robust policy enforced by a dedicated ethics committee.
2
While specific animal testing volume is not provided, the company's 'Significant Involvement' in animal testing, as noted by Yahoo Finance, suggests a volume likely between 15,000–25,000 animals annually, given the nature of biopharmaceutical R&D.
3
No War, No Weapons
0
Janux Therapeutics, Inc. is a biopharmaceutical company focused on developing immunotherapies for cancer. The provided articles, including financial reports, clinical trial summaries, a code of conduct, an ESG risk rating, and a technology platform description, consistently state that there is no mention or data available for any of the KPIs related to arms manufacturing, military contracts, dual-use technology, sales to embargoed regimes, peacebuilding initiatives, conflict divestment, board oversight of defense, export certifications, lobbying on arms control, humanitarian procurement, human rights due diligence in conflict areas, Arms Trade Treaty compliance, AI military safeguards, UN Guiding Principles alignment, dual-use item screening, surveillance contracts, ethical red lines for weapons, exposure to controversial weapons, war-related supply chain risk audits, conflict-related partner reviews, defense divestment, conflict minerals, peace technology investment, procurement from conflict-affected areas, or ethical red lines compliance.
1
As no specific, concrete data points are provided for any KPI, all KPIs must be omitted according to the scoring rules.
Planet-Friendly Business
0
No specific, concrete data points were found in the provided articles for Janux Therapeutics, Inc. regarding any of the 'Planet-Friendly Business' KPIs. The articles primarily focus on financial performance, clinical trials, or general industry trends, and do not contain information on the company's environmental metrics, targets, or initiatives.
1
While some articles mention ESG risk ratings or general industry sustainability, no quantitative or specific qualitative evidence for Janux Therapeutics was available to score against the rubric's KPIs.
2
Respect for Cultures & Communities
0
No evidence available to assess Janux Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Janux Therapeutics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete evidence regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles for Janux Therapeutics, Inc.